Related Experiment Video
Updated: Jun 18, 2026

04:33
Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
Published on: March 12, 2019
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function
Endocrine Development
|December 4, 2009
Summary
The hypothalamic-pituitary-adrenal (HPA) axis regulates homeostasis via neuroendocrine and immune pathways. Neurotransmitters and drugs significantly influence this axis, impacting HPA axis functionality tests.
Area of Science:
- Neuroendocrinology
- Neuroimmunology
Background:
- The hypothalamic-pituitary-adrenal (HPA) axis is a critical neuroendocrine system for maintaining body homeostasis.
- It integrates central nervous system (CNS) responses to stimuli, involving corticotropin-releasing hormone (CRH) and vasopressin (AVP), which stimulate ACTH release and adrenal steroidogenesis.
- HPA axis regulation involves diurnal rhythms, corticosteroid negative feedback, and modulation by numerous neurotransmitters and neuropeptides.
Purpose of the Study:
- To elucidate the complex regulatory mechanisms of the HPA axis.
- To understand the modulatory roles of various neurotransmitters, neuropeptides, and exogenous substances on HPA axis activity.
- To highlight the implications of these modulations for clinical testing of HPA axis functionality.
Main Methods:
- Review of established knowledge on HPA axis physiology and neurochemical regulation.
- Analysis of the effects of specific neuroactive substances (e.g., glucocorticoids, GABA agonists, opioids, endocannabinoids, serotonin, norepinephrine, dopamine, acetylcholine, ghrelin, angiotensin II, cytokines) on HPA axis components.
- Examination of how these modulations can interfere with diagnostic assessments of the HPA axis.
Main Results:
- The HPA axis is modulated by a wide array of endogenous and exogenous factors.
- Inhibitory modulators include synthetic glucocorticoids, GABA agonists, opioid peptides, and endocannabinoids, affecting cortisol secretion.
- Stimulatory modulators include serotonin, norepinephrine, dopamine, acetylcholine, ghrelin, angiotensin II, and cytokines, also influencing cortisol secretion.
Conclusions:
- The intricate interplay of neurotransmitters and neuropeptides significantly impacts HPA axis function.
- Neuroactive drugs targeting these pathways can alter ACTH and cortisol secretion.
- Understanding these modulatory effects is crucial for accurate interpretation of HPA axis functionality tests.
Related Concept Videos
Hypothalamic-Pituitary Axis
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Hormones of the Adrenal Glands
Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
